Structural effects of amino acid substitutions on the P21 proteins: Evidence for a malignant conformation
- 14 Downloads
- 9 Citations
Abstract
The conformational effects of different amino acid substitutions for Gly at position 12 in theras-oncogene-encoded P21 proteins have been investigated using conformational energy calculations. Mutations that cause amino acid substitutions for Gly 12 result in a protein that produces malignant transformation of cells. It had previously been shown that substitution of Val, Lys, or Ser for Gly at position 12 results in a major conformational change, and that the preferred lowest energy structure for each of the substituted peptides is identical. It is now found that substitution for Gly 12 of other amino acids that have widely disparate helix-nucleating potentials and completely different side chains (Asp, Asn, Cys, Phe, Tle, Leu, and Ala) all produce this identical lowest energy conformation. This finding is consistent with the recent results of site-specific mutagenesis experiments showing that P21 proteins containing these amino acids at position 12 all promote malignant transformation of cells and suggests the existence of a “malignancy-causing” conformation for the P21 proteins.
Key words
conformational energy three-dimensional structure amino acid substitution P21 proteins transformationPreview
Unable to display preview. Download preview PDF.
References
- Brandt-Rauf, P. W., and Pincus, M. R. (1984). Tenth Congress, European Society for Medical Oncology, p. 37.Google Scholar
- Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., and Goeddel, D. V. (1983).Nature 303, 33–37.Google Scholar
- Chang, E. H., Furth, M. A., Scolnick, E. M., and Lowy, D. R. (1982).Nature 297, 479–483.Google Scholar
- Dygert, M., Go, N., and Scheraga, H. A. (1975).Macromolecules 8, 750–761.Google Scholar
- Feramisco, J. R., Clark, R., Wong, G., Arnheim, N., Milley, R., and McCormick, F. (1985).Nature 314, 639–642.Google Scholar
- Miller, M. H., and Scheraga, H. A. (1976).J. Polymer Sci. Polymer Symp. 54, 171–200.Google Scholar
- Momany, F. A., McGuire, R. F., Burgess, A. W., and Scheraga, H. A. (1975).J. Phys. Chem. 79, 2361–2381.Google Scholar
- Murakami, M. (1985).J. Theor. Biol. 114, 193–198.Google Scholar
- Nemethy, G., and Scheraga, H. A. (1977).Q. Rev. Biophys. 10, 239–352.Google Scholar
- Pincus, M. R. (1985). InThe Molecular Basis of Cancer: An Interdisciplinary Discussion on Basic and Applied Aspects of Cancer (Rein, R., ed.), Liss, New York, pp. 419–430.Google Scholar
- Pincus, M. R., and Brandt-Rauf, P. W. (1985).Proc. Natl. Acad. Sci. USA 82, 3596–3600.Google Scholar
- Pincus, M. R., and Brandt-Rauf, P. W. (1984). Eighteenth Middle Atlantic Regional Meeting, American Chemical Society, p. 40.Google Scholar
- Pincus, M. R., and Klausner, R. D. (1982).Proc. Natl. Acad. Sci. USA 79, 3413–3417.Google Scholar
- Pincus, M. R., Klausner, R. D., and Scheraga, H. A. (1982).Proc. Natl. Acad. Sci. USA. 79, 5107–5110.Google Scholar
- Pincus, M. R., van Renswoude, J., Harford, J. B., Chang, E. H., Carty, R. P., and Klausner, R. D. (1983).Proc. Natl. Acad. Sci. USA 80, 5253–5257.Google Scholar
- Reddy, E. P., Reynolds, R. K., Santos, E., and Barbacid, M. (1982).Nature 300, 149–152.Google Scholar
- Santos, E., Reddy, E. P., Pulciani, S., Feldman, R. J., and Barbacid, M. (1983).Proc. Natl. Acad. Sci. USA 80, 4679–4683.Google Scholar
- Scheraga, H. A. (1984).Carlsberg Res. Commun. 49, 1–55.Google Scholar
- Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., and Levinson, A. D. (1984).Nature 312, 71–75.Google Scholar
- Simon, I., Nemethy, G., and Scheraga, H. A. (1980).Macromolecules 11, 797–804.Google Scholar
- Stacey, D. W., and Kung, H.-F. (1984).Nature 310, 508–511.Google Scholar
- Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., and Chang, E. H. (1982).Nature 300, 143–149.Google Scholar
- Zimmerman, S. S., Pottle, M. S., Nemethy, G., and Scheraga, H. A. (1977).Macromolecules 10, 1–9.Google Scholar